Home/Synergia Medical/Charles Nolet
CN

Charles Nolet

CEO

Synergia Medical

Therapeutic Areas

Synergia Medical Pipeline

DrugIndicationPhase
NAO.VNS™Drug-Resistant Epilepsy (via Vagus Nerve Stimulation)Phase 1